Mohamed Hamad J T Al-Thani, Sameh El-Saharty, Zeina Jamal, Amit Mishra, Suresh Babu Kokku, Rehana Nasir Nawaz, Ioanna Skaroni, Abdul Badi Abou-Samra
{"title":"Qatar's Progress in Curbing Diabetes: A Comprehensive and Proactive Approach.","authors":"Mohamed Hamad J T Al-Thani, Sameh El-Saharty, Zeina Jamal, Amit Mishra, Suresh Babu Kokku, Rehana Nasir Nawaz, Ioanna Skaroni, Abdul Badi Abou-Samra","doi":"10.1080/23288604.2025.2516897","DOIUrl":null,"url":null,"abstract":"<p><p>This commentary examines Qatar's proactive approach to addressing the rising prevalence of Type 2 diabetes mellitus and associated non-communicable diseases within the Gulf Cooperation Council region. Following the 2012 STEPwise survey, which revealed a T2DM prevalence of 16.7%, Qatar launched the National Diabetes Strategy (2016-2022), focusing on six strategic pillars. Recent data from the 2023 STEPwise survey indicates a stabilization in diabetes (18.1%) and obesity (33.4%) rates, alongside other lifestyle factors, necessitating ongoing public health interventions. Qatar leverages innovative technologies and digital health initiatives to enhance diabetes care and disease surveillance. The establishment of national taskforces for obesity and childhood diabetes further exemplifies Qatar's commitment to a coordinated response. Future directions include the National Health Strategy (NHS-3): Action Plan 2024-2030, on Obesity, Diabetes, and Modifiable Risk Factors for Atherosclerotic Cardiovascular Diseases, which aims to strengthen screening and management activities. By fostering partnerships and prioritizing research, Qatar aspires to improve health outcomes and serve as a model for other nations facing similar health challenges.</p>","PeriodicalId":73218,"journal":{"name":"Health systems and reform","volume":"11 1","pages":"2516897"},"PeriodicalIF":1.9000,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health systems and reform","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/23288604.2025.2516897","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/23 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This commentary examines Qatar's proactive approach to addressing the rising prevalence of Type 2 diabetes mellitus and associated non-communicable diseases within the Gulf Cooperation Council region. Following the 2012 STEPwise survey, which revealed a T2DM prevalence of 16.7%, Qatar launched the National Diabetes Strategy (2016-2022), focusing on six strategic pillars. Recent data from the 2023 STEPwise survey indicates a stabilization in diabetes (18.1%) and obesity (33.4%) rates, alongside other lifestyle factors, necessitating ongoing public health interventions. Qatar leverages innovative technologies and digital health initiatives to enhance diabetes care and disease surveillance. The establishment of national taskforces for obesity and childhood diabetes further exemplifies Qatar's commitment to a coordinated response. Future directions include the National Health Strategy (NHS-3): Action Plan 2024-2030, on Obesity, Diabetes, and Modifiable Risk Factors for Atherosclerotic Cardiovascular Diseases, which aims to strengthen screening and management activities. By fostering partnerships and prioritizing research, Qatar aspires to improve health outcomes and serve as a model for other nations facing similar health challenges.